CV 8102Alternative Names: CV-8102
Latest Information Update: 27 May 2016
At a glance
- Originator CureVac
- Class Adjuvants; RNA; RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Rabies
Most Recent Events
- 27 May 2016 Phase-I development is ongoing in Germany